English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Transoral endocrine surgery offers thyroid and parathyroid patients the option of surgery without any visible scar on the front of the neck. Aside from curiosity and excitement the operation has also generated several questions. One of the most commonly asked questions is in regard to eligibility for the procedure. In this context there are two types of eligibility, one that applies to individual patients and one that applies to the broader population. Patient-centered eligibility refers to those factors that make any particular individual patient eligible or ineligible for the operation. This information is important to allow surgeons and patients to make informed decisions when choosing between the traditional and transoral approach. Population-centered eligibility refers to the percentage of all thyroid and parathyroid patients that would be eligible for the procedure. This information is crucial for the larger philosophical question of whether the operation has intrinsic value, and whether or not the operation has enough merit to continue to pursue it as a new means of performing thyroid and parathyroid surgery. This article reviews both the patient and population-level eligibility to give a better understanding of not only which patients are eligible, but also what value this operation may have in the broader context of thyroid and parathyroid surgery.

Individual patient and population-level eligibility for transoral endocrine surgery